Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.
Identifieur interne : 000460 ( PubMed/Curation ); précédent : 000459; suivant : 000461Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.
Auteurs : Ebru Yalçin [Turquie] ; Deniz Do Ru ; Mithat Halilo Lu ; U Ur Ozçelik ; Nural Kiper ; Ayhan GöçmenSource :
- Respiration; international review of thoracic diseases [ 0025-7931 ]
Descripteurs français
- KwdFr :
- Administration par inhalation, Anti-inflammatoires (usage thérapeutique), Bronchiolite oblitérante (imagerie diagnostique), Bronchiolite oblitérante (physiopathologie), Bronchiolite oblitérante (traitement médicamenteux), Bronchiolite oblitérante (étiologie), Chloroquine (usage thérapeutique), Enfant d'âge préscolaire, Femelle, Hormones corticosurrénaliennes (administration et posologie), Humains, Mâle, Nourrisson, Nouveau-né, Prednisolone (usage thérapeutique), Pronostic, Reprise du traitement, Résultat thérapeutique, Tomodensitométrie, Études de suivi.
- MESH :
- administration et posologie : Hormones corticosurrénaliennes.
- imagerie diagnostique : Bronchiolite oblitérante.
- physiopathologie : Bronchiolite oblitérante.
- traitement médicamenteux : Bronchiolite oblitérante.
- usage thérapeutique : Anti-inflammatoires, Chloroquine, Prednisolone.
- étiologie : Bronchiolite oblitérante.
- Administration par inhalation, Enfant d'âge préscolaire, Femelle, Humains, Mâle, Nourrisson, Nouveau-né, Pronostic, Reprise du traitement, Résultat thérapeutique, Tomodensitométrie, Études de suivi.
English descriptors
- KwdEn :
- Administration, Inhalation, Adrenal Cortex Hormones (administration & dosage), Anti-Inflammatory Agents (therapeutic use), Bronchiolitis Obliterans (diagnostic imaging), Bronchiolitis Obliterans (drug therapy), Bronchiolitis Obliterans (etiology), Bronchiolitis Obliterans (physiopathology), Child, Preschool, Chloroquine (therapeutic use), Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Infections (complications), Male, Prednisolone (therapeutic use), Prognosis, Retreatment, Tomography, X-Ray Computed, Treatment Outcome.
- MESH :
- chemical , administration & dosage : Adrenal Cortex Hormones.
- chemical , therapeutic use : Anti-Inflammatory Agents, Chloroquine, Prednisolone.
- complications : Infections.
- diagnostic imaging : Bronchiolitis Obliterans.
- drug therapy : Bronchiolitis Obliterans.
- etiology : Bronchiolitis Obliterans.
- physiopathology : Bronchiolitis Obliterans.
- Administration, Inhalation, Child, Preschool, Female, Follow-Up Studies, Humans, Infant, Infant, Newborn, Male, Prognosis, Retreatment, Tomography, X-Ray Computed, Treatment Outcome.
Abstract
Postinfectious bronchiolitis obliterans (BO) designates a clinical syndrome of chronic airflow obstruction associated with inflammatory changes in the small airways.
DOI: 10.1159/000072900
PubMed: 14512672
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000460
Links to Exploration step
pubmed:14512672Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.</title><author><name sortKey="Yalcin, Ebru" sort="Yalcin, Ebru" uniqKey="Yalcin E" first="Ebru" last="Yalçin">Ebru Yalçin</name><affiliation wicri:level="1"><nlm:affiliation>Chest Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. ebruy@hacettepe.edu.tr</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Chest Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara</wicri:regionArea></affiliation></author><author><name sortKey="Do Ru, Deniz" sort="Do Ru, Deniz" uniqKey="Do Ru D" first="Deniz" last="Do Ru">Deniz Do Ru</name></author><author><name sortKey="Halilo Lu, Mithat" sort="Halilo Lu, Mithat" uniqKey="Halilo Lu M" first="Mithat" last="Halilo Lu">Mithat Halilo Lu</name></author><author><name sortKey="Ozcelik, U Ur" sort="Ozcelik, U Ur" uniqKey="Ozcelik U" first="U Ur" last="Ozçelik">U Ur Ozçelik</name></author><author><name sortKey="Kiper, Nural" sort="Kiper, Nural" uniqKey="Kiper N" first="Nural" last="Kiper">Nural Kiper</name></author><author><name sortKey="Gocmen, Ayhan" sort="Gocmen, Ayhan" uniqKey="Gocmen A" first="Ayhan" last="Göçmen">Ayhan Göçmen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="????"><PubDate><MedlineDate>2003 Jul-Aug</MedlineDate></PubDate></date><idno type="RBID">pubmed:14512672</idno><idno type="pmid">14512672</idno><idno type="doi">10.1159/000072900</idno><idno type="wicri:Area/PubMed/Corpus">000460</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000460</idno><idno type="wicri:Area/PubMed/Curation">000460</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000460</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.</title><author><name sortKey="Yalcin, Ebru" sort="Yalcin, Ebru" uniqKey="Yalcin E" first="Ebru" last="Yalçin">Ebru Yalçin</name><affiliation wicri:level="1"><nlm:affiliation>Chest Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. ebruy@hacettepe.edu.tr</nlm:affiliation><country xml:lang="fr">Turquie</country><wicri:regionArea>Chest Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara</wicri:regionArea></affiliation></author><author><name sortKey="Do Ru, Deniz" sort="Do Ru, Deniz" uniqKey="Do Ru D" first="Deniz" last="Do Ru">Deniz Do Ru</name></author><author><name sortKey="Halilo Lu, Mithat" sort="Halilo Lu, Mithat" uniqKey="Halilo Lu M" first="Mithat" last="Halilo Lu">Mithat Halilo Lu</name></author><author><name sortKey="Ozcelik, U Ur" sort="Ozcelik, U Ur" uniqKey="Ozcelik U" first="U Ur" last="Ozçelik">U Ur Ozçelik</name></author><author><name sortKey="Kiper, Nural" sort="Kiper, Nural" uniqKey="Kiper N" first="Nural" last="Kiper">Nural Kiper</name></author><author><name sortKey="Gocmen, Ayhan" sort="Gocmen, Ayhan" uniqKey="Gocmen A" first="Ayhan" last="Göçmen">Ayhan Göçmen</name></author></analytic><series><title level="j">Respiration; international review of thoracic diseases</title><idno type="ISSN">0025-7931</idno></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Inhalation</term><term>Adrenal Cortex Hormones (administration & dosage)</term><term>Anti-Inflammatory Agents (therapeutic use)</term><term>Bronchiolitis Obliterans (diagnostic imaging)</term><term>Bronchiolitis Obliterans (drug therapy)</term><term>Bronchiolitis Obliterans (etiology)</term><term>Bronchiolitis Obliterans (physiopathology)</term><term>Child, Preschool</term><term>Chloroquine (therapeutic use)</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Infections (complications)</term><term>Male</term><term>Prednisolone (therapeutic use)</term><term>Prognosis</term><term>Retreatment</term><term>Tomography, X-Ray Computed</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Administration par inhalation</term><term>Anti-inflammatoires (usage thérapeutique)</term><term>Bronchiolite oblitérante (imagerie diagnostique)</term><term>Bronchiolite oblitérante (physiopathologie)</term><term>Bronchiolite oblitérante (traitement médicamenteux)</term><term>Bronchiolite oblitérante (étiologie)</term><term>Chloroquine (usage thérapeutique)</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Hormones corticosurrénaliennes (administration et posologie)</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Prednisolone (usage thérapeutique)</term><term>Pronostic</term><term>Reprise du traitement</term><term>Résultat thérapeutique</term><term>Tomodensitométrie</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenal Cortex Hormones</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents</term><term>Chloroquine</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Hormones corticosurrénaliennes</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Infections</term></keywords><keywords scheme="MESH" qualifier="diagnostic imaging" xml:lang="en"><term>Bronchiolitis Obliterans</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Bronchiolitis Obliterans</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Bronchiolitis Obliterans</term></keywords><keywords scheme="MESH" qualifier="imagerie diagnostique" xml:lang="fr"><term>Bronchiolite oblitérante</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Bronchiolite oblitérante</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Bronchiolitis Obliterans</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Bronchiolite oblitérante</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Anti-inflammatoires</term><term>Chloroquine</term><term>Prednisolone</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Bronchiolite oblitérante</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Administration, Inhalation</term><term>Child, Preschool</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Infant</term><term>Infant, Newborn</term><term>Male</term><term>Prognosis</term><term>Retreatment</term><term>Tomography, X-Ray Computed</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Administration par inhalation</term><term>Enfant d'âge préscolaire</term><term>Femelle</term><term>Humains</term><term>Mâle</term><term>Nourrisson</term><term>Nouveau-né</term><term>Pronostic</term><term>Reprise du traitement</term><term>Résultat thérapeutique</term><term>Tomodensitométrie</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Postinfectious bronchiolitis obliterans (BO) designates a clinical syndrome of chronic airflow obstruction associated with inflammatory changes in the small airways.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14512672</PMID><DateCompleted><Year>2004</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2019</Year><Month>12</Month><Day>10</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0025-7931</ISSN><JournalIssue CitedMedium="Print"><Volume>70</Volume><Issue>4</Issue><PubDate><MedlineDate>2003 Jul-Aug</MedlineDate></PubDate></JournalIssue><Title>Respiration; international review of thoracic diseases</Title><ISOAbbreviation>Respiration</ISOAbbreviation></Journal><ArticleTitle>Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.</ArticleTitle><Pagination><MedlinePgn>371-5</MedlinePgn></Pagination><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Postinfectious bronchiolitis obliterans (BO) designates a clinical syndrome of chronic airflow obstruction associated with inflammatory changes in the small airways.</AbstractText><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this study was to determine the etiology, clinical and radiological features and define prognostic factors of postinfectious BO in children.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">We undertook a review of the medical records of 20 children with postinfectious BO, who were followed up between January 1994 and August 2001.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Postinfectious BO was diagnosed in 11 boys and 9 girls with a median age of 21.5 months (6-69 months) who were followed up for a median of 23 months. Cough and wheezing persisted since the initial lung infection in all patients. Postinfectious BO was diagnosed in an average of 6 months (1-42 months) after the acute illness. Adenoviruses were the most common etiologic agents identified serologically. The diagnoses of postinfectious BO was made by thoracic high-resolution computed tomography and clinical features. Corticosteroid therapy was used in 17 patients and supportive treatment was applied in all patients. Age at initial lung infection, gender, time of starting corticosteroid treatment, presence of bronchiectasis or atelectasis and etiologic agents identified on presentation did not predict severity in our study.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Despite the prominent role of inflammation in the pathogenesis of postinfectious BO, the use of anti-inflammatory agents remains controversial. We could not identify any prognostic factors related to disease severity. In order to minimize associated complications, patients with postinfectious BO should be closely followed up and receive meticulous lung care.</AbstractText><CopyrightInformation>Copyright 2003 S. Karger AG, Basel</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yalçin</LastName><ForeName>Ebru</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Chest Diseases Unit, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey. ebruy@hacettepe.edu.tr</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Doğru</LastName><ForeName>Deniz</ForeName><Initials>D</Initials></Author><Author ValidYN="Y"><LastName>Haliloğlu</LastName><ForeName>Mithat</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Ozçelik</LastName><ForeName>Uğur</ForeName><Initials>U</Initials></Author><Author ValidYN="Y"><LastName>Kiper</LastName><ForeName>Nural</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Göçmen</LastName><ForeName>Ayhan</ForeName><Initials>A</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Respiration</MedlineTA><NlmUniqueID>0137356</NlmUniqueID><ISSNLinking>0025-7931</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>886U3H6UFF</RegistryNumber><NameOfSubstance UI="D002738">Chloroquine</NameOfSubstance></Chemical><Chemical><RegistryNumber>9PHQ9Y1OLM</RegistryNumber><NameOfSubstance UI="D011239">Prednisolone</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001989" MajorTopicYN="N">Bronchiolitis Obliterans</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002738" MajorTopicYN="N">Chloroquine</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007231" MajorTopicYN="N">Infant, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007239" MajorTopicYN="N">Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011239" MajorTopicYN="N">Prednisolone</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019233" MajorTopicYN="N">Retreatment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014057" MajorTopicYN="Y">Tomography, X-Ray Computed</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2002</Year><Month>03</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2003</Year><Month>03</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2004</Year><Month>1</Month><Day>21</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>9</Month><Day>27</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14512672</ArticleId><ArticleId IdType="doi">10.1159/000072900</ArticleId><ArticleId IdType="pii">72900</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= ChloroquineV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:14512672
|texte= Postinfectious bronchiolitis obliterans in children: clinical and radiological profile and prognostic factors.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:14512672" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a ChloroquineV1
| This area was generated with Dilib version V0.6.33. |  |